Clinical Trials
GC Biopharma and Novel Pharma Receive FDA Fast Track Designation for Sanfilippo Syndrome Treatment GC1130A
GC Biopharma (006280. KS) and Novel Pharma have announced that the U.S. FDA has granted Fast Track Designation for their jointly developed MPSIIIA (Sanfili...
June 11, 2024 | News
DeepQure Initiates Early Feasibility Study for Groundbreaking HyperQure™ System Following FDA Approval
DeepQure, a Seoul based medical device company with a novel, extravascular (laparoscopic approach) solution for renal denervation (RDN), announce...
June 11, 2024 | News
Vertex's TRIKAFTA® Shows Significant Clinical Benefits in Cystic Fibrosis Patients with Rare Mutations
Results from a randomized, placebo-controlled study of TRIKAFTA® in people with cystic fibrosis with rare, non-F508del CFTR mutations s...
June 10, 2024 | News
MLB Receives FDA Approval for TML-6 IND Application to Treat Alzheimer's Disease
MLB (Merry Life Biomedical Company, Ltd., Taiwan ) a biomedical company, announced that the U.S. Food and Drug Administration (FDA) h...
June 07, 2024 | News
Shanghai MicuRx Achieves Key Milestone in Combatting Drug-Resistant Infections with Successful Phase I Trial of MRX-8
According to the World Health Organization (WHO), millions of patients face treatment difficulties or even life-threatening conditions due to resistant b...
June 07, 2024 | News
I-Mab Partners with Bristol Myers Squibb for Phase 1 Clinical Trial of Novel Cancer Therapy
I-Mab , a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapi...
June 06, 2024 | News
Thermo Fisher Scientific Opens Cutting-Edge Ultra-Cold Facility in EU to Boost Advanced Therapy Development
Thermo Fisher Scientific Inc., the world leader in serving science, has opened a new clinical and commercial ultra-cold facility in the EU, expanding its c...
June 03, 2024 | News
AstraZeneca’s TAGRISSO® Shows Significant Improvement in Progression-Free Survival in Phase III LAURA Trial for EGFR-Mutated NSCLC
Positive results from the LAURA Phase III trial showed AstraZeneca’s TAGRISSO® (osimertinib) demonstrated a statistically significant a...
June 03, 2024 | News
EMA CHMP Recommends Approval of Sugemalimab for First-Line Treatment of NSCLC
EMA CHMP recommendation is based on the results of a Phase 3 clinical trial (GEMSTONE-302) demonstrating significant progression-free survival (PFS) and ...
June 03, 2024 | News
Fortrea Launches Comprehensive Solution to Enhance Diversity and Inclusion in Clinical Trials
Fortrea, a leading global contract research organization (CRO), today announced its comprehensive and integrated solution to improve the diversity an...
May 31, 2024 | News
Kexing Biopharm’s Subsidiary Receives Approval for Clinical Trials of Innovative GB08 Growth Hormone
Kexing Biopharm announced that Shenzhen Kexing Pharmaceutical Co., Ltd., its wholly-owned subsidiary, recently received a Notice of Approval for Drug Clini...
May 31, 2024 | News
HanAll Biopharma Secures Exclusive Rights to Cutting-Edge Aging Reprogramming Technology
Exclusive agreement allows HanAll to utilize Epigenetic Reprogramming of Aging (ERATM) technology for ophthalmic and otic diseases. Collaboration aims t...
May 29, 2024 | News
Innovent Biologics Announces Phase 3 Success for Picankibart in Treating Moderate to SevereInnovent Biologics Announces Phase 3 Success for Picankibart in Treating Moderate to Severe Plaque Psoriasis
Innovent Biologics, a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of canc...
May 28, 2024 | News
Neuren Pharmaceuticals Announces Positive Phase 2 Trial Results for NNZ-2591 in Pitt Hopkins Syndrome
Neuren Pharmaceuticals revealed top-line results from its Phase 2 clinical trial of NNZ-2591 in children with Pitt Hopkins syndrome (PTHS). This trial demo...
May 28, 2024 | News
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
